Emily J Culme-Seymour

Medicine · Health Sciences

12h-index1.2kcitations33works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Biomedical Ethics and Regulation(20), Pluripotent Stem Cells Research(11), Tissue Engineering and Regenerative Medicine(8), Tracheal and airway disorders(6), Biomedical and Engineering Education(6)

Publications33 total

Feasibility of manufacture of chimeric antigen receptor-regulatory T cells from patients with end-stage renal disease
Translational Medicine Communications·2023· 5 citedOpen Access
Study Design: Human Leukocyte Antigen Class I Molecule A∗02-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation
Kidney International Reports·2022· 57 citedOpen Access
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
The Lancet Haematology·2019· 201 citedOpen Access
Evolving Industry Partnerships and Investments in Cell and Gene Therapies
Cell stem cell·2018· 4 citedOpen Access
Evolving Industry Partnerships and Investments in Cell and Gene Therapies
Cell stem cell·2018· 11 citedOpen Access
Lancet Commission: Stem cells and regenerative medicine
The Lancet·2017· 271 citedOpen Access
Cell & Gene Therapy, and Regenerative Medicine – Different Definitions
Cell and Gene Therapy Insights·2016· 5 cited
452. RegenVOX - Translational Exploitation Strategy for Stem Cell-Based Tissue-Engineered Laryngeal Implants Undergoing Phase I/II Clinical Trial
Molecular Therapy·2016Open Access
Reply to: “Recent Advances in Circumferential Tracheal Replacement and Transplantation”
American Journal of Transplantation·2016· 3 citedOpen Access
Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case Series
Tissue Engineering Part A·2015· 24 cited
Cell and gene therapies: improving and extending quality of life for seniors
Cell and Gene Therapy Insights·2015
Cell Therapy Regulatory Toolkit: an Online Regulatory Resource
Regenerative Medicine·2015· 5 cited
Turning Regenerative Medicine Breakthrough Ideas and Innovations into Commercial Products
Tissue Engineering Part B Reviews·2015· 23 cited
Tissue-Engineered Tracheal Replacement in a Child: A 4-Year Follow-Up Study
American Journal of Transplantation·2015· 175 citedOpen Access
RegenVOX: a Phase I/II clinical trial of stem cell-based tissue-engineered laryngeal implants
Cytotherapy·2015· 1 cited
Cost of stem cell-based tissue-engineered airway transplants in the UK: Case series
Cytotherapy·2015
Establishing the necessary data to model the future resource requirements and predicted healthcare targets for cell therapy as part of routine clinical practice
Journal of Cell Science and Therapy·2013
Cell Therapy Companies Make Strong Progress from October 2012 to March 2013 Amid Mixed Stock Market Sentiment
Cell stem cell·2013· 19 citedOpen Access
A new cell therapy sector arising from the convergence of cell and gene therapy
Cytotherapy·2013· 2 cited
Global Update: UK
Regenerative Medicine·2012· 3 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Chris Mason(18), Martin Birchall(7), Mark W. Lowdell(6), David Brindley(5), Natasha L. Davie(5), Nicholas Hamilton(4), Colin R. Butler(4), Claire Crowley(4), Paolo De Coppi(3), Jeff Round(3), Gillian Atkinson(3), Ed Toll(3), Sam M. Janes(3), Brock Reeve(3), Julian Hitchcock(2), Derek Roebuck(2), Richard Hewitt(2), R. Cetto(2), Christopher O’Callaghan(2), Christopher E. Mason(2)